• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Improving Outcomes in Patients With Diabetes Mellitus.改善糖尿病患者的结局。
J Am Heart Assoc. 2019 Feb 19;8(4):e011971. doi: 10.1161/JAHA.119.011971.
2
Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".萨塔尔等人对关于“2型糖尿病诊断年龄及其与心血管和死亡风险的关联”一文的信件的回应。
Circulation. 2019 Oct 15;140(16):e724-e725. doi: 10.1161/CIRCULATIONAHA.119.042457. Epub 2019 Oct 14.
3
Letter by Wang et al Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".王等人就“2型糖尿病诊断年龄及其与心血管和死亡风险的关联”一文所写的信。
Circulation. 2019 Oct 15;140(16):e720-e721. doi: 10.1161/CIRCULATIONAHA.119.042061. Epub 2019 Oct 14.
4
The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease.糖尿病合并冠状动脉疾病患者的最佳血压水平：持续不断的传奇故事。
J Am Heart Assoc. 2018 Oct 16;7(20):e010752. doi: 10.1161/JAHA.118.010752.
5
Comment on Li et al. Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes. Diabetes Care 2023;46:425-433.关于李等人的评论。血清尿酸与糖尿病全因死亡率和心血管死亡率的关联。《糖尿病护理》2023年；46:425 - 433。
Diabetes Care. 2024 Mar 1;47(3):e31. doi: 10.2337/dc22-2466.
6
Capsule Commentary for Raghavan et al., Association of Glycemic Control Trajectory with Short-term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study.拉贾万等人的胶囊评论，高心血管风险糖尿病患者血糖控制轨迹与短期死亡率的关联：一项联合潜在类别建模研究
J Gen Intern Med. 2020 Aug;35(8):2518. doi: 10.1007/s11606-020-05902-2.
7
Letter by Wang and Xu Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".王和徐就《2型糖尿病诊断年龄及其与心血管和死亡风险的关联》一文所写的信。
Circulation. 2019 Oct 15;140(16):e722-e723. doi: 10.1161/CIRCULATIONAHA.119.041840. Epub 2019 Oct 14.
8
Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.1型糖尿病患者存在额外的心血管疾病风险。
Circulation. 2019 Feb 5;139(6):744-747. doi: 10.1161/CIRCULATIONAHA.118.038137.
9
With regard to the papers by Kumar et al. and de Leeuw and de Boer addressing the cardiovascular safety and efficacy of anti-diabetic drugs.关于库马尔等人以及德·利乌和德·布尔撰写的探讨抗糖尿病药物心血管安全性和疗效的论文。
Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):75-76. doi: 10.1093/ehjcvp/pvw047.
10
Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".坦帕基斯等人就文章《恩格列净与2型糖尿病、已确诊心血管疾病及慢性肾脏病患者的临床结局》所写的信
Circulation. 2018 Aug 21;138(8):848-849. doi: 10.1161/CIRCULATIONAHA.117.032720.

本文引用的文献

1
Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.糖尿病相关全因和心血管死亡率在一个全国成年人队列中。
J Am Heart Assoc. 2019 Feb 19;8(4):e011295. doi: 10.1161/JAHA.118.011295.
2
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry.美国糖尿病患者复合心血管风险因素目标达标情况及其预测因素：糖尿病协作登记处。
Diabetes Obes Metab. 2019 May;21(5):1121-1127. doi: 10.1111/dom.13625. Epub 2019 Feb 14.
3
9. Pharmacologic Approaches to Glycemic Treatment: .9. 血糖治疗的药物学方法： 。
Diabetes Care. 2019 Jan;42(Suppl 1):S90-S102. doi: 10.2337/dc19-S009.
4
6. Glycemic Targets: .6. 血糖目标： 。
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70. doi: 10.2337/dc19-S006.
5
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.2018年美国心脏病学会专家共识决策路径：2型糖尿病合并动脉粥样硬化性心血管疾病患者降低心血管风险的新型疗法：美国心脏病学会专家共识决策路径特别工作组报告
J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26.
6
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.
7
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.阿必鲁肽与伴有心血管疾病的 2 型糖尿病患者的心血管结局（Harmony Outcomes）：一项双盲、随机、安慰剂对照试验。
Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.
8
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.2 型糖尿病患者的风险因素、死亡率和心血管结局。
N Engl J Med. 2018 Aug 16;379(7):633-644. doi: 10.1056/NEJMoa1800256.
9
Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.美国有和无诊断糖尿病的成年人特定病因死亡率趋势：基于全国调查和生命统计数据的流行病学分析。
Lancet. 2018 Jun 16;391(10138):2430-2440. doi: 10.1016/S0140-6736(18)30314-3. Epub 2018 May 18.
10
Economic Costs of Diabetes in the U.S. in 2017.2017 年美国糖尿病的经济成本。
Diabetes Care. 2018 May;41(5):917-928. doi: 10.2337/dci18-0007. Epub 2018 Mar 22.

改善糖尿病患者的结局。

Improving Outcomes in Patients With Diabetes Mellitus.

机构信息

1 Department of Epidemiology, Human Genetics and Environmental Sciences School of Public Health University of Texas Health Science Center at Houston TX.

2 Division of Cardiology UT McGovern Medical School Houston TX.

出版信息

J Am Heart Assoc. 2019 Feb 19;8(4):e011971. doi: 10.1161/JAHA.119.011971.

DOI:10.1161/JAHA.119.011971
PMID:30776984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405648/
Abstract

See Article by Raghavan et al.

摘要

见 Raghavan 等人的文章。